...
首页> 外文期刊>Future medicinal chemistry >Antitumoral activity of 1,2-diaminocyclohexane derivatives in breast, colon and skin human cancer cells
【24h】

Antitumoral activity of 1,2-diaminocyclohexane derivatives in breast, colon and skin human cancer cells

机译:1,2-二氨基环己烷衍生物在乳腺,结肠和皮肤人癌细胞中的抗肿瘤活性

获取原文
获取原文并翻译 | 示例
           

摘要

Aim: Cancer is among the leading causes of death worldwide. Medical interest has focused on macrocyclic polyamines because of their properties as antitumor agents. Results/Methodology: We have designed and synthesized a series of 1,2-diaminocyclohexane derivatives with notable in vitro antiproliferative activities against the MCF-7, HCT-116 and A375 cancer cell lines. Cell cycle and apoptosis analyses were also carried out. Our results show that all the compounds are potent cytotoxic agents, especially against the A375 cell line. Conclusion: The selective activity of the macrocyclic derivative against A375, via apoptosis, supposes a great advantage for future therapeutic use. This exemplifies the potential of 1,2-diaminocyclohexane derivatives to qualify as lead structures for future anticancer drug development due to their easy syntheses and noteworthy bioactivity.
机译:目的:癌症是全世界死亡的主要原因。 由于其属性作为抗肿瘤剂,医学兴趣的重点是宏环多胺。 结果/方法:我们已经设计和合成了一系列1,2-二氨基环己烷衍生物,其具有针对MCF-7,HCT-116和A375癌细胞系的显着的体外抗增殖活动。 还进行了细胞周期和凋亡分析。 我们的研究结果表明,所有化合物都是有效的细胞毒性剂,特别是对A375细胞系。 结论:通过细胞凋亡,通过凋亡的宏环衍生物对A375的选择性活性,假设未来治疗用途具有很大的优势。 这举例说明了1,2-二氨基环己烷衍生物的潜力,因为它们易于合成和值得注意的生物活性,由于其易于抗癌药物开发的铅结构。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号